Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Second Quarter 2016 Financial Results

Genmab will report its Second Quarter 2016 financial results after market close on August 9. An investor conference call to discuss the results will be held at 6:00 PM CEST / 12:00 PM EDT on August 9. To join the call by phone, dial one of the following numbers and ask for the Genmab conference call or provide the confirmation code 4509710 if asked: +4532 71 16 58 in Denmark, +44 20 3427 1914 in the UK or +1 212 444 0481 in the US. Click here to listen to the webcast. 


Lab tourVirtual Lab Tour

Watch our new virtual lab tour to learn more about Genmab’s research and development capabilities and our proprietary DuoBody® and HexaBody® technologies.

Join our teamCareer Opportunities at Genmab

Genmab is seeking new employees to join our teams in Copenhagen and Utrecht. Visit our Careers web pages to explore our current vacancies, learn about our culture and meet some of our team members